The Nuclear Physics Division of the EPS
The European Physical Society (EPS) is a learned society whose aims are to promote physics in a European context and to provide a forum for individual physicists across Europe to exchange ideas. The Nuclear Physics Division was established four decades ago to assist the advancement and dissemination of knowledge of Nuclear Physics. It promotes the subject through the organisation of conferences and summer schools, by furthering the exchange of scientists and the award of major prizes to recognise outstanding achievement in the subject.
The Division has recently established a series of 3-yearly European Nuclear Physics conferences spanning the full breadth of the subject. The 2013 IBA Prize for Applied Nuclear Science and Nuclear Methods in Medicine is awarded to Prof. Marco Durante "for his outstanding and seminal contributions to research topics in the field of radiation biophysics, including work in clinical and space radiobiology, particle genetic damage and therapy, and his valuable activities in the scientific community."
Below are a few highlights of Prof. Durante's work. Prof. Durante has had a long and distinguished career in radiation biophysics. His Ph.D. (Naples 1988) was carried out in this field and since then he has gone on to become a world-leading authority.
Before the development of microbeams he proposed a method to detect and measure biological effects of charged-particles using solid state nuclear track detectors. Mammalian cells grown on thin mylar films were exposed to accelerated He-ions. Cells were then incubated for colony formation, and the colonies traced back to the recorded cell images to determine the fate of the single cells and the fraction surviving irradiation.
Prof Durante has spent many years analysing chromosomal aberrations induced by heavy ions. At NASA Johnson Space Center, he combined the methods of premature chromosome condensation (PCC) and fluorescence in situ hybridization (FISH) to study the formation of chromosomal aberrations in human cells. The results proved that the kinetics of formation of chromosomal aberrations after heavy ions has the same mechanism and follows the same shape as for sparsely ionizing radiation, although quantitative differences were observed. Later he applied variations of this technique (mFISH, mBAND, and RxFISH) to cells exposed to heavy ions and his studies pointed out qualitative differences in the aberrations induced by heavy ions, particularly a large increase in complex-type exchanges.
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He has been instrumental in the development of a novel technique for premature chromosome condensation, based on the action of a phosphatise inhibitor, calyculin A, which he developed together with Dr. Eisuke Gotoh. The method is now largely used in biodosimetry, especially after exposure to heavy ions. A review paper by Prof. Durante and Dr. Gotoh [2] summarizes the results.
Prof Durante is a leading expert in biological effects of space radiation, and advises ESA on radiobiology. Since 2000 he has led a large International Collaboration including European, Japanese and US research centers for studying biological effects of shielded heavy ions. These studies helped demonstrate that light, hydrogen rich materials, such as polyethylene, are more effective than high-Z materials for protection from cosmic rays. Shielding tests with new materials are currently being carried out on the International Space Station. He has worked on biodosimetry in astronauts and has analysed blood cells from Russian cosmonauts involved in long-term space missions (up to 750 days in space). The study of chromosomal aberrations led to the interesting observation that the radiosensitivity decreases in later flights compared to the first mission. These results may point to an acquired radioresistance induced by exposure to space flight. He has published review papers on space radiation research in leading International journals, including a recent review in Lancet Oncology [3] .
Prof. Durante's expertise in the biophysics of heavy ions has also been applied in several studies dealing with cancer hadrontherapy. At the Chiba National Institute for Radiological Center (Japan), he studied tissue samples from similar patients treated with either X-rays or high-energy carbon ions. The comparison demonstrated that, although C-ions are more effective in the induction of genetic damage per unit dose, the damage in the patient is reduced, because of the better dose localization and minimized normal tissue damage in hadrontherapy. This research is continuing at GSI where recent work has focused on the difficulties of moving targets. In conclusion Prof Durante has made an outstanding contribution to our understanding of radiation biophysics and is a very worthy winner of the 2013 IBA Prize.
